Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

Morris, M. J., Heller, G., Hillman, D. W., Bobek, O., Ryan, C., Antonarakis, E. S., Bryce, A. H., Hahn, O., Beltran, H., Armstrong, A. J., Schwartz, L., Lewis, L. D., Beumer, J. H., Langevin, B., McGary, E. C., Mehan, P. T., Goldkorn, A., Roth, B. J., Xiao, H., … Small, E. J. (2023). Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of Clinical Oncology, 41(18), 3352–3362. https://doi.org/10.1200/jco.22.02394
Authors:
Michael J Morris
Glenn Heller
David W Hillman
Olivia Bobek
Charles Ryan
Emmanuel S Antonarakis
Alan H Bryce
Olwen Hahn
Himisha Beltran
Andrew J Armstrong
Lawrence Schwartz
Lionel D Lewis
Jan H Beumer
Brooke Langevin
Eric C McGary
Paul T Mehan
Amir Goldkorn
Bruce J Roth
Han Xiao
Colleen Watt
Mary-Ellen Taplin
Susan Halabi
Eric J Small
Affiliated Authors:
Lawrence Schwartz
Publication Type:
Article
Unique ID:
10.1200/jco.22.02394
PMID:
Publication Date:
Data Source:
PubMed

Record Created: